|
|
 |
ADVAIR HFA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACTOPLUS MET Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACCRUFER Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS DEXTROSE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$798.00 |
|
|
 |
ADASUVE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
APLENZIN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|